≡ ADHD Patch Provides Tolerable And Effective Symptom Control
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the complete specialty biopharmaceutical fleet, announced that information from a 12-month become accomplished at of DAYTRANATM (methylphenidate transdermal system), the Attention Deficit Hyperactivity Disorder (ADHD) patch, demonstrated that DAYTRANA provide crucial ADHD tolerability and symptom keeping advance contained by family aged 6 to 12 years.
[…]
